DM Bio is a biopharmaceutical manufacturing company which is located in Incheon, South Korea.
Dong-A Socio Holdings, the No. 1 Korean pharmaceutical company, and Meiji Seika Pharma which has advanced R&D capabilities and know-how from Japan, jointly established DM Bio.
We are committed to leading our clients' projects successfully by providing High Quality Products and Exquisite Service.
- Maximizing Production Efficiency through Hybrid System
- Multiple Independent Production Lines for mAb and Recombinant Proteins
- Non-GMP and GMP manufacturing facility lines for efficient process development and technology transfer
- Initial process development in the early stage through the scale-down validation studies at small scale
- Complying with Global Guidelines
- Experts with experience from R&D and cGMP facility
Please fill out your name and email address to send an inquiry to the contact listed above.